Our previous results demonstrated that in response to LIX1 silencing, GIST cells lose KIT expression, a signature of GIST cell identity, and acquire smooth muscle features, a quality associated with reduced proliferative and invasive capacities. The gene discussed is LIX1; the disease is gastrointestinal stromal tumor.